These findings suggest that behavioral medicine should shift its focus to outcomes meaningful to patients, rather than surrogate immunologic markers. Future work should prioritize functional capacity, health-related quality of life, and life expectancy as primary endpoints.
Robert M. Kaplan (Thu,) studied this question.